At the state level in the United States are allowed to use cannabis for research purposes
The US government now will not only provide financial resources for the study of the properties of hemp, but also to distribute them among the state scientific and research institutions wishing to participate in such activities.
August 11 Drug Enforcement Administration (DEA) US made an official statement to the media that after careful consideration of the issue of the reclassification of psychoactive hemp, experts of state institutions came to the conclusion that cannabis should be left in the list of especially dangerous drugs, turnover of which is prohibited. However, the US DEA authorizes employees of the state of scientific and research institutions, officially to study the therapeutic properties of the psychoactive cannabis, using state budget funds.
On the criticism has fallen on the part of the civilian community in the US immediately after the announcement of the decision, the standard answer was given that the medicinal properties of cannabis is documented in the country have not been proved, so the psychoactive cannabis is a plant, forbidden to all activities at the federal level, in addition to the possibility of its research and application of scientific purposes.
Comment of the Association "Ukrainian industrial hemp"
Hemp US industry and a huge number of citizens of the country, the official presentation of the various public organizations over the last decade require the federal government changes to existing legislation. The Americans are fighting for something that psychoactive hemp was officially changed to the status of a particularly dangerous drug on the medication adjustment. One of the catalysts of this process in 2016, it became an open letter from a group of influential politicians and US doctors, offering the opportunity to develop a number of areas of modern konoplevodstva using hemp as a raw material for the manufacture of pharmaceutical and medical products.
For criticism of the US decision adopted by the DEA until nobody wants to notice the key provisions significantly alter the state approaches to the study of the possibility of using cannabisa as a therapeutic agent. Prior to the announcement of the official decision of the Office for the fight against drugs, the DEA is a monopolist in the market study psychoactive properties of cannabis, and studies were carried out on a single plantation in the country at the University of Mississippi. The US government now will not only provide financial resources for the study of the properties of hemp, but also to distribute them among the state scientific and research institutions wishing to participate in such activities. In addition, criticism is no one pays attention to the statement by government officials that in case of providing for the consideration of the results of clinical trials demonstrating the effectiveness of the medical properties of cannabis, the government is ready to re-examine the question of exceptions psychoactive hemp from the corresponding list and giving cannabisu status drug, whose turnover is limited.
Changing the policy in relation to psychoactive hemp US federal agencies must be carried out extremely interesting lobbyists in Ukraine reform of national legislation, which are aimed at formalization of the possibility of using hemp for research purposes. It should be remembered that the draft legal act is currently under consideration by the Supreme Council of Ukraine separate novellas secured the use of cannabis for research purposes. The debate on this issue in our country takes place precisely in the plane, to provide a possibility of this kind of research only government agencies or to work within the framework of this problem and also to private business.
Information taken from the site http://tku.org.ua